Sort
15,440 grants matching “organoids”
Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer
$203,026Philip M Spanheimer · Univ Of North Carolina Chapel Hill · K08 · FY2023 · CA
Ultra-bright fluorescent nanoparticles for colorectal adenoma detection
$202,990Jatin Roper · Duke University · R21 · FY2022 · DK
Use of lingual organoids to screen for the impact of targeted cancer therapies on taste bud renewal
$202,928Linda A Barlow · University Of Colorado Denver · R21 · FY2020 · CA
Isolation and in vitro maintenance of intact colonic crypts from normal human col
$202,928James Varani · University Of Michigan At Ann Arbor · R21 · FY2014 · CA
Ultrafast Dynamic contract optical coherence tomography for high-throughput anti-cancer drug screening
$202,917Yuye Ling · University Of Oklahoma · P20 · FY2025 · GM
Mural stem cells in normal development and germinal matrix hemorrhage in the preterm human brain
$202,878Elizabeth Erin Crouch · University Of California, San Francisco · K08 · FY2021 · NS
Mural stem cells in normal development and germinal matrix hemorrhage in the preterm human brain
$202,878Elizabeth Erin Crouch · University Of California, San Francisco · K08 · FY2022 · NS
Core B: Molecular/Functional Measurement Core
$202,679Martina Gentzsch · Univ Of North Carolina Chapel Hill · P30 · FY2020 · DK
Core C: Cell Models Core
$202,679Scott H Randell · Univ Of North Carolina Chapel Hill · P30 · FY2020 · DK
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer
$202,669Keith T Wilson · Vanderbilt University Medical Center · P01 · FY2016 · CA
Role of Iron and B-Catenin Activation in Gastric Carcinogenesis
$202,640Richard M Peek · Vanderbilt University Medical Center · P01 · FY2016 · CA
Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy
$202,561Saraswathi Viswanathan · University Of Nebraska Medical Center · R21 · FY2019 · CA
Full Research Project 2: Unusual DNA methylation phenotype in Colorectal Cancer
$202,538Carmen Sapienza · Temple Univ Of The Commonwealth · U54 · FY2025 · CA
Generating morphogen gradients to engineer human integumentary organoids
$202,500Hasan Erbil Abaci · Columbia University Health Sciences · R21 · FY2021 · EB
Generating morphogen gradients to engineer human integumentary organoids
$202,500Hasan Erbil Abaci · Columbia University Health Sciences · R21 · FY2020 · EB
The Functions of Novel FOXN1 Compound Heterozygous Mutations in PIDs Patients
$202,500Nicolai Stanislas Cyrille Van Oers · Ut Southwestern Medical Center · R21 · FY2020 · AI
Regulation of H. Pylori Virulance by Dietary Factors that Impact Gastric Cancer
$202,441Timothy L Cover · Vanderbilt University Medical Center · P01 · FY2016 · CA
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
$202,379Pei Wang · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Core 3: Preclinical Models and Therapeutics Core
$202,291Giorgio Inghirami · New York University School Of Medicine · P01 · FY2023 · CA
Development of a CF10 Predictive Gene Signature in CRC Organoids.
$202,275William H Gmeiner · Wake Forest University Health Sciences · R21 · FY2018 · CA
Isolation and in vitro maintenance of intact colonic crypts from normal human col
$202,275James Varani · University Of Michigan At Ann Arbor · R21 · FY2015 · CA
MyD88-dependent mechanisms of Helicobacter pylori-induced gastric cancer progression
$202,275Marygorret Obonyo · University Of California, San Diego · R21 · FY2017 · CA
Isolation and in vitro maintenance of intact colonic crypts from normal human col
$202,275James Varani · University Of Michigan At Ann Arbor · R21 · FY2016 · CA
Stem Cell, Organoid and Cell Phenotyping Module
$202,222Danielle M Robertson · Ut Southwestern Medical Center · P30 · FY2025 · EY
Stem Cell, Organoid and Cell Phenotyping Module
$202,222Danielle M Robertson · Ut Southwestern Medical Center · P30 · FY2024 · EY